TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $375,955 | +27.1% | 24,997 | 0.0% | 0.04% | +19.4% |
| Q4 2022 | $295,715 | +10.3% | 24,997 | -44.8% | 0.03% | +14.8% |
| Q3 2022 | $268,000 | +58.6% | 45,313 | +14.2% | 0.03% | +58.8% |
| Q2 2022 | $169,000 | -55.2% | 39,675 | 0.0% | 0.02% | -46.9% |
| Q1 2022 | $377,000 | -49.5% | 39,675 | +1.1% | 0.03% | -46.7% |
| Q4 2021 | $746,000 | -41.9% | 39,247 | +1.8% | 0.06% | -47.8% |
| Q3 2021 | $1,283,000 | -13.7% | 38,552 | +0.5% | 0.12% | -16.1% |
| Q2 2021 | $1,487,000 | -19.1% | 38,347 | +0.6% | 0.14% | -23.9% |
| Q1 2021 | $1,837,000 | +17.9% | 38,114 | +27.3% | 0.18% | +8.4% |
| Q4 2020 | $1,558,000 | – | 29,942 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |